Form 8-K - Current report:
SEC Accession No. 0001789769-23-000067
Filing Date
2023-05-11
Accepted
2023-05-11 07:05:49
Documents
14
Period of Report
2023-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K til-20230511.htm   iXBRL 8-K 45547
2 EX-99.1 q1-23er.htm EX-99.1 57759
6 GRAPHIC imagea.jpg GRAPHIC 3565
  Complete submission text file 0001789769-23-000067.txt   258571

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20230511.xsd EX-101.SCH 1890
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20230511_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20230511_pre.xml EX-101.PRE 13036
8 EXTRACTED XBRL INSTANCE DOCUMENT til-20230511_htm.xml XML 12735
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 23908768
SIC: 2836 Biological Products, (No Diagnostic Substances)